Rani Therapeutics Hldgs Q2 EPS $(0.37) Down From $(0.31) YoY
Portfolio Pulse from Benzinga Newsdesk
Rani Therapeutics Hldgs (NASDAQ:RANI) reported a 19.35% increase in its quarterly losses, with an EPS of $(0.37) compared to $(0.31) in the same period last year.
August 11, 2023 | 8:11 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rani Therapeutics Hldgs reported a 19.35% increase in its quarterly losses, which could negatively impact investor sentiment.
Rani Therapeutics Hldgs reported a 19.35% increase in its quarterly losses, which is a negative signal for investors. This could lead to a decrease in the company's stock price in the short term as it indicates a worsening financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100